BiotechTube
Home/OCON Therapeutics/Susan Alpert, PhD, MD
SA

Susan Alpert, PhD, MD

Senior Regulatory Advisor

OCON Therapeutics

Therapeutic Areas

ContraceptionAbnormal Uterine BleedingHeavy Menstrual BleedingEndometriosisUterine FibroidsInfertility

OCON Therapeutics Pipeline

DrugIndicationPhase
IUB® BALLERINE®Hormone‑free contraceptionPhase 2
IUB® SEAD®Abnormal uterine bleeding / heavy menstrual bleedingPhase 2
IUB® PRIMA®Endometriosis, uterine fibroids, hormonal disordersPre‑clinical

Leadership Team at OCON Therapeutics

KL
Keren Leshem
Chief Executive Officer
AA
Amir Avraham
Chief Financial Officer & General Manager
DS
Daniela Schardinger
VP Marketing & Medical Affairs
AL
Adely Levy
VP Regulatory Affairs / Quality Assurance
View full OCON Therapeutics profile